Scancell【SCLP】銘柄情報

Scancell Hldgs Plc (SCLP) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

15.00

( -10.71% )

買値

14.50

売値

15.50

出来高

3,294,952

14.75 日の範囲 17.05

7.90 52 週間の範囲 29.50

時価総額

155.667M

前日終値

16.80

始値

17.00

時刻

50000

15.23

(O)

最終取引時間

財務取引量

543,667p

VWAP

16.50

平均取引量 (3 か月)

2,281,422p

発行済株式数

1,037,781,403

配当利回り

PER

-23.46

1 株当たり利益 (EPS)

-0.01

歳入

4.71M

純利益

-5.51M

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.scancell.co.uk

本社

Oxford, United Kingdom

設立

1996

Scancell Hldgs Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker SCLP. The last closing price for Scancell was 16.80p. Over the last year, Scancell shares have traded in a share price range of 7.90p to 29.50p.

Scancell currently has 1,037,781,403 shares in issue. The market capitalisation of Scancell is £155.67 million. Scancell has a price to earnings ratio (PE ratio) of -23.46.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-5.5	-26.8292682927	20.5	20.5	14.75	2847635	17.46191038	DE
4	-8	-34.7826086957	23	23	14.75	1575945	19.14914293	DE
12	3	25	12	29.5	12	2364656	19.33021863	DE
26	5.1	51.5151515152	9.9	29.5	9.9	1861730	16.48123227	DE
52	5.5	57.8947368421	9.5	29.5	7.9	1422685	14.14109208	DE
156	1.75	13.2075471698	13.25	29.5	7.25	982874	13.03508539	DE
260	-6.25	-29.4117647059	21.25	29.5	7.25	927502	14.91154796	DE